MedPath

Comparison of sutures for skin closure in cesarean section

Not yet recruiting
Conditions
Pregnant women at period of gestation more than 37 weeks
Registration Number
CTRI/2018/07/014979
Lead Sponsor
Department of OBG
Brief Summary

Cesarean Section is a common procedure and till now consensus on skin closure tachniques remain elusive. common skin closure techniques are are Subcuticular sutures and Staples. Among sutures two most widely used sutures for low transverse cesarean section skin closure are poligPoliglecapreo and polyblactin -910. As there is difference in profile for each suture and physiologic wound healing process,present study is planned to evaluate these two suture materials for subcuticular skin closure.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
200
Inclusion Criteria

Singleton pregnancy Period of gestation more than 37 complete d weeks.

Exclusion Criteria

Vertical skin incision Premature rupture of membranes Chorioamniotis Intauterine fetal death Utu within 2 weeks before CS Frank sepsis BMI more than 35 Emergency CS requiring urgent fetal delivery Situations where antibiotic could not be given at least 30 min before skin incision Diabetes mellitus on insulin Local skin infection at site of incision General anesthesia Use of systemic steroids during pregnancy for 2 weeks or greater Any chronic medical illness Frank sepsis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite wound complications as defined by CDCPain at day 3 | Scar at 6 weeks post operatively | Wound infection at any time up to 6 weeks
Secondary Outcome Measures
NameTimeMethod
PainCosmetic appearance

Trial Locations

Locations (1)

Antenatal ward/labour ward

🇮🇳

Kangra, HIMACHAL PRADESH, India

Antenatal ward/labour ward
🇮🇳Kangra, HIMACHAL PRADESH, India
Shikha Sharma
Principal investigator
8988335505
sharmashikha1178@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.